Enantioselective Synthesis of PPAR (Peroxisome Proliferator-Activated Receptors) Agonists and Antagonists

被引：1
|
作者：
Goya, Pilar [1 ]
Perez-Fernandez, Ruth [1 ]
Gonzalez-Muniz, Rosario [1 ]
Elguero, Jose [1 ]
机构：
[1] CSIC, Inst Quim Med, E-28006 Madrid, Spain
来源：
CURRENT TOPICS IN MEDICINAL CHEMISTRY | 2014年 / 14卷 / 10期
关键词：
PPAR; enantioselective separation; enantioselective synthesis; Evans' chiral auxiliary; asymmetric hydrogenation; chiral HPLC; chiral salts; PHENYLPROPANOIC ACID-DERIVATIVES; EFFICIENT ASYMMETRIC-SYNTHESIS; ALPHA/GAMMA DUAL AGONISTS; LIGAND-BINDING DOMAIN; BIOLOGICAL EVALUATION; ALPHA AGONIST; DESIGN; POTENCY; AGENTS;
D O I：
10.2174/1568026614666140423112822
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
This review deals with stereoselective issues in PPAR ligands some of which are in clinical use for treating certain metabolic disorders. After a short introduction of these nuclear receptor and their agonists, some cases of enantioselective separations are reported. The main part concerns stereoselective synthesis first starting with asymmetric synthesis from chiral precursors followed by what we refer to as "true" enantioselective methods. Some examples are discussed in detail for each particular heading.
引用
收藏
页码：1283 / 1293
页数：11
相关论文
共 50 条
  • [1] Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the 'future' in dermatology therapeutics?
    Gupta, Mrinal
    Mahajan, Vikram K.
    Mehta, Karaninder S.
    Chauhan, Pushpinder S.
    Rawat, Ritu
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2015, 307 (09) : 767 - 780
  • [2] Peroxisome Proliferator-Activated Receptors (PPAR) Agonists as Master Modulators of Tumor Tissue
    Heudobler, Daniel
    Rechenmacher, Michael
    Lueke, Florian
    Vogelhuber, Martin
    Pukrop, Tobias
    Herr, Wolfgang
    Ghibelli, Lina
    Gerner, Christopher
    Reichle, Albrecht
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (11)
  • [3] Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics?
    Mrinal Gupta
    Vikram K. Mahajan
    Karaninder S. Mehta
    Pushpinder S. Chauhan
    Ritu Rawat
    Archives of Dermatological Research, 2015, 307 : 767 - 780
  • [4] Peroxisome proliferator-activated receptor (PPAR)γ agonists for diabetes
    Moller, DE
    Greene, DA
    ADVANCES IN PROTEIN CHEMISTRY, VOL 56: DRUG DISCOVERY AND DESIGN, 2001, 56 : 181 - +
  • [5] Synthesis of a unique dimethyl thiazoline containing intermediate of novel peroxisome proliferator-activated receptors(PPAR)δ agonists
    Kadayat, Tara Man
    Lee, Geumwoo
    Jung, Kyungjin
    Hwang, Hee-Jong
    Joo, Jeongmin
    Hahn, Dongyup
    Hwang, Hayoung
    Park, Keun-Gyu
    Cho, Sung Jin
    Kim, Kyung-Hee
    Chin, Jungwook
    TETRAHEDRON LETTERS, 2018, 59 (50) : 4384 - 4386
  • [6] Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis
    Neve, BP
    Fruchart, JC
    Staels, B
    BIOCHEMICAL PHARMACOLOGY, 2000, 60 (08) : 1245 - 1250
  • [7] The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR)
    Peraza, MA
    Burdick, AD
    Marin, HE
    Gonzalez, FJ
    Peters, JM
    TOXICOLOGICAL SCIENCES, 2006, 90 (02) : 269 - 295
  • [8] Peroxisome proliferator-activated receptors (PPAR). Antiproliferative properties
    Hojka, Anna
    Rapak, Andrzej
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2011, 65 : 404 - 413
  • [9] Inhibition of cell proliferation by potential peroxisome proliferator-activated receptor (PPAR) gamma agonists and antagonists
    Lea, MA
    Sura, M
    Desbordes, C
    ANTICANCER RESEARCH, 2004, 24 (5A) : 2765 - 2771
  • [10] The role of peroxisome proliferator-activated receptors (PPAR) in immune responses
    Christofides, Anthos
    Konstantinidou, Eirini
    Jani, Chinmay
    Boussiotis, Vassiliki A.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 114
12345